KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Debt to Equity (2016 - 2017)

Historic Debt to Equity for Arbutus Biopharma (ABUS) over the last 2 years, with Q4 2017 value amounting to $0.07.

  • Arbutus Biopharma's Debt to Equity rose 1125.21% to $0.07 in Q4 2017 from the same period last year, while for Dec 2017 it was $0.07, marking a year-over-year increase of 1125.21%. This contributed to the annual value of $0.07 for FY2017, which is 1125.21% up from last year.
  • As of Q4 2017, Arbutus Biopharma's Debt to Equity stood at $0.07, which was up 1125.21% from $0.07 recorded in Q3 2017.
  • Arbutus Biopharma's 5-year Debt to Equity high stood at $0.07 for Q3 2017, and its period low was $0.06 during Q4 2016.